CN113456575A - Multi-effect pore astringent formula and preparation method thereof - Google Patents
Multi-effect pore astringent formula and preparation method thereof Download PDFInfo
- Publication number
- CN113456575A CN113456575A CN202110915965.3A CN202110915965A CN113456575A CN 113456575 A CN113456575 A CN 113456575A CN 202110915965 A CN202110915965 A CN 202110915965A CN 113456575 A CN113456575 A CN 113456575A
- Authority
- CN
- China
- Prior art keywords
- composition
- extract
- preparation
- water
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
- A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/28—Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Tropical Medicine & Parasitology (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Cosmetics (AREA)
Abstract
The invention belongs to the technical field of cosmetics, and discloses a multi-effect pore astringent formula and a preparation method thereof, wherein the preparation comprises a group A preparation comprising water, p-hydroxyacetophenone, butanediol, a 1, 2-hexanediol composition, propylene glycol, allantoin, glyceryl polyether-26 and betaine, and a group B preparation comprising a PCA sodium composition, a glycerin composition, a Hamamelis virginiana water composition, a caprylyl hydroximic acid composition, a rose water composition, a Chrysanthemum indicum extract composition, a Feverfew extract composition, a medicinal fomes fomentarius extract, nicotinamide and panthenol. The skin is more permeable, the nutrients can enter, the metabolism can be discharged, pores can be converged, the skin is tender, smooth and clean, and the pores are finer and smoother.
Description
Technical Field
The invention belongs to the technical field of cosmetics, and particularly relates to a formula of multi-effect pore astringent lotion and a preparation method thereof.
Background
Astringent is a common cosmetic lotion, and has the effects of balancing skin pH value, regulating oil secretion, supplementing lost water, controlling oil and keeping moisture. Most of the existing astringent agents which are astringent only temporarily can shrink expanded pores into a tight state or improve the visual impression of the pores from the outside, but cannot really shrink the pores, so that the problem of the pores which cannot be fundamentally improved is solved, and the astringent effect is not durable.
Disclosure of Invention
In order to solve the problems in the prior art, the invention aims to provide a multi-effect pore astringent lotion formula and a preparation method thereof.
The technical scheme adopted by the invention is as follows: a multi-effect pore astringent formula and a preparation method thereof comprise A, B groups of preparations, wherein the ingredients of the A group of preparations comprise water, p-hydroxyacetophenone, butanediol, 1, 2-hexanediol composition, propylene glycol, allantoin, glyceryl polyether-26 and betaine, the ingredients of the B group of preparations comprise PCA sodium composition, glycerin composition, Hamamelis virginiana water composition, caprylyl hydroximic acid composition, rose water composition, golden yellow chamomile extract composition, feverfew extract composition, medicinal fomes fomentarius extract, nicotinamide and panthenol, and the preparation method of the preparation comprises the following steps:
s1: cleaning and disinfecting production equipment and tools;
s2: sequentially adding the group A preparations into a main pot, starting steam, stirring (15 HZ), heating to 80-85 ℃, then closing circulating water, homogenizing (40 HZ) for 1min, uniformly dispersing, preserving heat for 20-30 min, and then cooling;
s3: cooling to 40-45 deg.C, sequentially adding the group B preparations, stirring, and inspecting after self-inspection is qualified;
s4: and (5) discharging through 800-mesh filter cloth after quality control inspection is qualified.
Further, the percentage ratios of the components of the preparation are water (63.05%), p-hydroxyacetophenone (0.25%), butanediol (3%), 1, 2-hexanediol composition (2%), propylene glycol (2%), allantoin (0.1%), glyceryl polyether-26 (2%), betaine (2%), sodium PCA composition (1.5%), glycerin composition (0.2%), hamamelis water composition (15%), caprylyl hydroximic acid composition (0.4%), rose water composition (5%), chamomile extract composition (0.1%), feverfew extract composition (0.4%), fomes officinalis extract (0.5%), nicotinamide (2%), and panthenol (0.5%).
Furthermore, the 1, 2-hexanediol composition (2%) includes water (63.5%), butanediol (20%), glyceryl polyether-26 (10%), 1, 2-hexanediol (2%), β -glucan (1%), glycerin (1%), sodium hyaluronate (2%), caprylyl glycol (0.45%), and sodium benzoate (0.05%).
Further, the sodium PCA composition (1.5%) included water (51%), sodium PCA (15%), sodium lactate (10%), sodium citrate (12%), glutamic acid (2%).
Still further, the glycerol composition (0.2%) included butylene glycol (10%), glycerol (5%), sodium lactate (3%), serine (1%), glycine (1%), alanine (5%), arginine (5%), aspartic acid (5%), valine (5%), isoleucine (5%), leucine (5%), glutamic acid (5%), potassium hydroxide (5%), proline (5%), citric acid (5%), water (30%) in a proportion.
Furthermore, the hamamelis water composition (15%) comprises hamamelis water (99.85%) and methylparaben (0.15%).
Further, the caprylyl hydroxamic acid composition (0.4%) contained caprylyl hydroxamic acid (10%), propylene glycol (88.7%), and glyceryl caprylate (1.3%).
Furthermore, the rose water composition (5%) comprises rose water (94.2%), propylene glycol (5%), caprylyl hydroximic acid, glyceryl caprylate, 1, 2-pentanediol (total 0.5%), p-hydroxyacetophenone (0.3%).
Further, the camomile extract composition (0.1%) included water (35%), butylene glycol (20%), camomile extract (10%), glycerin (8%), field mint leaf extract (7%), geranium extract (7%), purslane extract (6%), aloe vera extract (3%), sophora flavescens root extract (3%), sodium benzoate (0.5%), potassium sorbate (0.5%); the composition of feverfew extract (0.4%) included water (26%), butylene glycol (10%), propylene glycol (10%), feverfew extract (15%), tea extract (10%), turmeric extract (10%), centella asiatica extract (3%), 1, 2-hexanediol (1%), lactobacillus fermentation product (5%), magnolol (5%), lecithin (5%).
Furthermore, the medicinal fomes fomentarius extract (0.5%) comprises butanediol (50.9%), medicinal fomes fomentarius extract (48%), phenoxyethanol (0.8%), and PEG-40 hydrogenated castor oil (0.3%).
The invention has the beneficial effects that:
the formula of the multi-effect pore astringent and the preparation method thereof provided by the invention are a formula of the multi-effect pore astringent and the preparation method thereof, which can combine four effects of softening cutin, relieving and calming, refining pores and repairing barriers into a whole, and the multi-effect pore astringent is cleaned and nourished by the formula of the multi-effect pore astringent and the preparation method thereof, so that the skin can be more permeable, nutrients can come in, and metabolic energy can be discharged.
Lactic acid, lactobionic acid and salicylic acid in the components clean dirt in pores, soften cutin and enable blackheads to emerge; the natural components of the hamamelis virginiana, the calendula officinalis, the turmeric root and the like have plant energy to astringe pores, so that the skin is tender, smooth and clean, and the pores are finer and smoother.
Detailed Description
The present invention is further illustrated below with reference to specific examples.
Example 1:
the embodiment provides a multi-effect pore astringent formula and a preparation method thereof, the multi-effect pore astringent formula comprises A, B groups of preparations, the ingredients of the A group of preparations comprise water, p-hydroxyacetophenone, butanediol, 1, 2-hexanediol composition, propylene glycol, allantoin, glyceryl polyether-26 and betaine, the ingredients of the B group of preparations comprise PCA sodium composition, glycerin composition, Hamamelis virginiana water composition, caprylyl hydroximic acid composition, rose water composition, golden chamomile extract composition, feverfew extract composition, fomes officinalis extract, nicotinamide and panthenol, and the preparation method of the preparation comprises the following steps:
s1: cleaning and disinfecting production equipment and tools; s2: sequentially adding the group A preparations into a main pot, starting steam, stirring (15 HZ), heating to 80-85 ℃, then closing circulating water, homogenizing (40 HZ) for 1min, uniformly dispersing, preserving heat for 20-30 min, and then cooling; s3: cooling to 40-45 deg.C, sequentially adding the preparations of group B, stirring, and inspecting after self-inspection is qualified. S4: and (5) discharging through 800-mesh filter cloth after quality control inspection is qualified.
Specifically, the percentage ratios of the components of the preparation are water (63.05%), p-hydroxyacetophenone (0.25%), butanediol (3%), 1, 2-hexanediol composition (2%), propylene glycol (2%), allantoin (0.1%), glyceryl polyether-26 (2%), betaine (2%), sodium PCA composition (1.5%), glycerin composition (0.2%), hamamelis water composition (15%), caprylyl hydroximic acid composition (0.4%), rose water composition (5%), chamomile extract composition (0.1%), feverfew extract composition (0.4%), fomes officinalis extract (0.5%), nicotinamide (2%) and panthenol (0.5%).
Specifically, the 1, 2-hexanediol composition (2%) includes water (63.5%), butanediol (20%), glyceryl polyether-26 (10%), 1, 2-hexanediol (2%), beta-glucan (1%), glycerin (1%), sodium hyaluronate (2%), caprylyl glycol (0.45%), sodium benzoate (0.05%), the sodium PCA composition (1.5%) includes water (51%), sodium PCA (15%), sodium lactate (10%), sodium citrate (12%), glutamic acid (2%), the glycerin composition (0.2%) includes butanediol (10%), glycerin (5%), sodium lactate (3%), serine (1%), glycine (1%), alanine (5%), arginine (5%), aspartic acid (5%), Valine (5%), isoleucine (5%), leucine (5%), glutamic acid (5%), potassium hydroxide (5%), proline (5%), citric acid (5%), water (30%), hamamelis water composition (15%) in the ratio including hamamelis water (99.85%), methylparaben (0.15%), octanoyl hydroximic acid composition (0.4%) in the ratio including octanoyl hydroximic acid (10%), propylene glycol (88.7%), glyceryl caprylate (1.3%), rose water composition (5%) in the ratio including rose water (94.2%), propylene glycol (5%), octanoyl hydroximic acid, glyceryl caprylate, 1, 2-pentanediol (0.5%), p-hydroxyacetophenone (0.3%), chamomile extract composition (0.1%) in the ratio including water (35%), (water, citric acid, 5%), and sodium hydroxide (5%), (0.4%) Butylene glycol (20%), a chamomile extract (10%), glycerol (8%), a peppermint leaf extract (7%), a geranium extract (7%), a purslane extract (6%), an aloe barbadensis extract (3%), a picrasma root extract (3%), sodium benzoate (0.5%), and potassium sorbate (0.5%); the composition of feverfew extract (0.4%) comprises water (26%), butanediol (10%), propylene glycol (10%), feverfew extract (15%), tea extract (10%), turmeric root extract (10%), centella asiatica extract (3%), 1, 2-hexanediol (1%), lactobacillus fermentation product (5%), magnolol (5%), lecithin (5%), and fomes officinalis extract (0.5%) comprises butanediol (50.9%), fomes officinalis extract (48%), phenoxyethanol (0.8%), and PEG-40 hydrogenated castor oil (0.3%).
The present invention is not limited to the above-described alternative embodiments, and various other forms of products can be obtained by anyone in light of the present invention. The above detailed description should not be taken as limiting the scope of the invention, which is defined in the claims, and which the description is intended to be interpreted accordingly.
Claims (10)
1. A multi-effect pore astringent prescription and a preparation method thereof are characterized in that: a, B group preparation is included, the components of the A group preparation comprise water, p-hydroxyacetophenone, butanediol, 1, 2-hexanediol composition, propylene glycol, allantoin, glyceryl polyether-26 and betaine, the components of the B group preparation comprise PCA sodium composition, glycerin composition, Hamamelis virginiana water composition, caprylyl hydroximic acid composition, rose water composition, golden chamomile extract composition, feverfew extract composition, fomes officinalis extract, nicotinamide and panthenol, and the preparation method of the preparation comprises the following steps:
s1: cleaning and disinfecting production equipment and tools;
s2: sequentially adding the group A preparations into a main pot, starting steam, stirring (15 HZ), heating to 80-85 ℃, then closing circulating water, homogenizing (40 HZ) for 1min, uniformly dispersing, preserving heat for 20-30 min, and then cooling;
s3: cooling to 40-45 deg.C, sequentially adding the group B preparations, stirring, and inspecting after self-inspection is qualified;
s4: and (5) discharging through 800-mesh filter cloth after quality control inspection is qualified.
2. The multi-effect pore astringent formula and the preparation method thereof according to claim 1, wherein the formula comprises the following components: the preparation comprises, by percentage, water (63.05%), p-hydroxyacetophenone (0.25%), butanediol (3%), a 1, 2-hexanediol composition (2%), propylene glycol (2%), allantoin (0.1%), glyceryl polyether-26 (2%), betaine (2%), a PCA sodium composition (1.5%), a glycerin composition (0.2%), a Hamamelis virginiana water composition (15%), a caprylyl hydroximic acid composition (0.4%), a rose water composition (5%), a golden yellow chamomile extract composition (0.1%), a feverfew extract composition (0.4%), a medicinal fomes officinalis extract (0.5%), nicotinamide (2%) and panthenol (0.5%).
3. The multi-effect pore astringent formula and the preparation method thereof according to claim 2, wherein the formula comprises the following components: the proportion of the 1, 2-hexanediol composition (2%) comprises water (63.5%), butanediol (20%), glycerol polyether-26 (10%), 1, 2-hexanediol (2%), beta-glucan (1%), glycerol (1%), sodium hyaluronate (2%), caprylyl glycol (0.45%) and sodium benzoate (0.05%).
4. The multi-effect pore astringent formula and the preparation method thereof according to claim 2, wherein the formula comprises the following components: the sodium PCA composition (1.5%) included water (51%), sodium PCA (15%), sodium lactate (10%), sodium citrate (12%), glutamic acid (2%).
5. The multi-effect pore astringent formula and the preparation method thereof according to claim 2, wherein the formula comprises the following components: the glycerol composition (0.2%) included butylene glycol (10%), glycerol (5%), sodium lactate (3%), serine (1%), glycine (1%), alanine (5%), arginine (5%), aspartic acid (5%), valine (5%), isoleucine (5%), leucine (5%), glutamic acid (5%), potassium hydroxide (5%), proline (5%), citric acid (5%), and water (30%).
6. The multi-effect pore astringent formula and the preparation method thereof according to claim 2, wherein the formula comprises the following components: the Hamamelis virginiana water composition (15%) comprises Hamamelis virginiana water (99.85%), and methylparaben (0.15%).
7. The multi-effect pore astringent formula and the preparation method thereof according to claim 2, wherein the formula comprises the following components: the ratio of the caprylyl hydroximic acid composition (0.4%) comprises caprylyl hydroximic acid (10%), propylene glycol (88.7%) and glyceryl caprylate (1.3%).
8. The multi-effect pore astringent formula and the preparation method thereof according to claim 2, wherein the formula comprises the following components: the rose water composition (5%) comprises rose water (94.2%), propylene glycol (5%), caprylyl hydroximic acid, glyceryl caprylate, 1, 2-pentanediol (total 0.5%), p-hydroxyacetophenone (0.3%).
9. The multi-effect pore astringent formula and the preparation method thereof according to claim 2, wherein the formula comprises the following components: the golden yellow chamomile extract composition (0.1%) comprises water (35%), butanediol (20%), a golden yellow chamomile extract (10%), glycerol (8%), a field mint leaf extract (7%), a geranium extract (7%), a purslane extract (6%), an aloe barbadensis extract (3%), a picrasma kurarianum root extract (3%), sodium benzoate (0.5%) and potassium sorbate (0.5%); the composition of feverfew extract (0.4%) included water (26%), butylene glycol (10%), propylene glycol (10%), feverfew extract (15%), tea extract (10%), turmeric extract (10%), centella asiatica extract (3%), 1, 2-hexanediol (1%), lactobacillus fermentation product (5%), magnolol (5%), lecithin (5%).
10. The multi-effect pore astringent formula and the preparation method thereof according to claim 2, wherein the formula comprises the following components: the medicinal fomes fomentarius extract (0.5%) comprises butanediol (50.9%), medicinal fomes fomentarius extract (48%), phenoxyethanol (0.8%), and PEG-40 hydrogenated castor oil (0.3%).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110915965.3A CN113456575A (en) | 2021-08-11 | 2021-08-11 | Multi-effect pore astringent formula and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110915965.3A CN113456575A (en) | 2021-08-11 | 2021-08-11 | Multi-effect pore astringent formula and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113456575A true CN113456575A (en) | 2021-10-01 |
Family
ID=77866367
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110915965.3A Withdrawn CN113456575A (en) | 2021-08-11 | 2021-08-11 | Multi-effect pore astringent formula and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113456575A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114748389A (en) * | 2022-04-29 | 2022-07-15 | 彭氏(惠州)实业发展有限公司 | Essence water and preparation method thereof |
CN115120548A (en) * | 2022-07-11 | 2022-09-30 | 广州市韵柯莱化妆品科技有限公司 | Long-acting moisturizing repairing water and preparation method thereof |
CN116421511A (en) * | 2023-03-06 | 2023-07-14 | 广州善草纪化妆品有限公司 | 5 alpha-reductase inhibitor and preparation method and application thereof |
-
2021
- 2021-08-11 CN CN202110915965.3A patent/CN113456575A/en not_active Withdrawn
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114748389A (en) * | 2022-04-29 | 2022-07-15 | 彭氏(惠州)实业发展有限公司 | Essence water and preparation method thereof |
CN114748389B (en) * | 2022-04-29 | 2024-03-22 | 彭氏(惠州)实业发展有限公司 | Essence liquid and preparation method thereof |
CN115120548A (en) * | 2022-07-11 | 2022-09-30 | 广州市韵柯莱化妆品科技有限公司 | Long-acting moisturizing repairing water and preparation method thereof |
CN116421511A (en) * | 2023-03-06 | 2023-07-14 | 广州善草纪化妆品有限公司 | 5 alpha-reductase inhibitor and preparation method and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN113456575A (en) | Multi-effect pore astringent formula and preparation method thereof | |
CN108210357A (en) | A kind of multiple-effect water conservation spraying facial mask | |
KR101827258B1 (en) | Method of Preparing Soap Composition for Preventing Hair Loss or Accelerating Hair Growth and product of there of | |
CN103565728A (en) | Lycium ruthenicum mill whitening and moisturizing smoothing toner and preparation method of smoothing toner | |
CN106074306A (en) | A kind of for skin and the compositions of hair maintenance and application | |
CN115569105B (en) | Composition containing rice hull extract for removing dandruff, controlling oil, inhibiting bacteria and removing mites | |
CN108113932A (en) | Ms's anticreep shampoo | |
CN105326724B (en) | A kind of bamboo juice skin cream and preparation method thereof | |
CN105476950A (en) | Additive-free natural moisturizing foam face wash | |
CN110946817A (en) | Natural herbal skin mucosa disinfectant special for private parts of women | |
CN114886787A (en) | Oil control essence and preparation method thereof | |
CN103932949A (en) | Tartaric-acid-containing pore refining cleansing oil and preparation method thereof | |
CN111012733B (en) | Premna microphylla lactic acid face application agent | |
JP2004323424A (en) | Moisture-keeping plant extract, and external preparation, cosmetic, bath agent and detergent all containing the extract | |
CN105342927A (en) | Composition for removing under-eye puffiness and preparation method thereof | |
JP2004115483A (en) | Moisture retention vegetable extract and moisture retention agent for external use, cosmetic, bathing agent and detergent composition each containing the extract | |
CN109394622B (en) | Leg slimming essence lotion | |
CN110623888A (en) | Herbal soothing essence and preparation method thereof | |
CN114224754B (en) | A composition containing plant extract for regulating scalp oil secretion, brightening hair and smoothing hair, and shampoo containing the composition | |
JP2004115484A (en) | Moisture retention vegetable extract and moisture retention agent for external use, cosmetic, bathing agent and detergent composition each containing the extract | |
KR101200920B1 (en) | Cleansing composition comprising extracts from saponine containing plants using mineral-high mineral water | |
CN114569530A (en) | Preparation method of skin care product of organic natural plant preservative system | |
CN114159327A (en) | Mild hair-care type infant shampoo and preparation method thereof | |
CN110664720A (en) | Dendrobium officinale essence lotion and preparation method thereof | |
CN112156029A (en) | Camellia oil-control mite-removal amino acid cleansing mousse and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20211001 |
|
WW01 | Invention patent application withdrawn after publication |